PCRX logo
PCRX NASDAQ US

Pacira BioSciences, Inc. - Common Stock

Healthcare · Pharmaceuticals Sito web · IPO Feb 2011
$22,70
▼ $-0,09 (-0,39%)
Vol. 750K
12
Punteggio di Qualità
ok
Analisi approfondita
2/5 ok
Cap. mercato
$1.1B
P/E
51,9
ROE
2,8%
Margine
3,0%
D/E
51,80
Beta
0,25
52W
$18–$28

Consenso Wall Street

13 analisti · Apr 2026
3
Acquisto forte
6
Compra
3
Mantieni
1
Vendi
0
Vendita forte
69,2%
Rating Compra

Grafico dei Prezzi

Titoli simili

COLL
Collegium Pharmaceutical Inc
P/E 25,0
$1.5B
XERS
Xeris Biopharma Holdings Inc
$1.3B
AMPH
Amphastar Pharmaceuticals Inc
P/E 11,0
$1.2B
PHAT
Phathom Pharmaceuticals Inc
$1.2B
BIOA
BIOAGE Labs Inc
$474.4M
OMER
Omeros Corp
$1.2B
SGP
SpyGlass Pharma Inc
RLMD
Relmada Therapeutics Inc
$354.2M

Utili

Tasso di battuta: 75,0%
Prossimo report Mag 06, 2026
Stima EPS: $0,59
Trimestre EPS Stimato EPS Effettivo Sorpresa
Mar 2026 $0,59 — —
Dic 2025 $0,92 $0,57 $-0,35
Set 2025 $0,66 $0,70 +$0,04
Giu 2025 $0,72 $0,74 +$0,02

Trend fondamentali

Metrica 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -16.5% -16.5% -16.5% -16.5% 2.8% 2.8%
P/E (TTM) — — — — 48.26 51.94
Net Margin -2.7% -18.1% -18.1% -18.1% 3.0% 3.0%
Gross Margin 77.4% 78.2% 78.2% 78.2% 79.2% 79.2%
D/E Ratio 76.61 76.61 76.61 76.61 51.80 51.80
Current Ratio 2.38 2.38 2.38 2.38 5.26 5.26

Rapporti chiave

ROA (TTM)
1,4%
P/S (TTM)
1,55
P/B
1,1
EPS (TTM)
$0,47
CF/Share
$1,93
Crescita ricavi 3A
+9,0%
52W High
$27,64
52W Low
$18,17
$18,17 Intervallo 52 settimane $27,64

Як PCRX виглядає на тлі конкурентів у Pharmaceuticals?

Група порівняння: Micro-cap Pharmaceuticals (All) · 171 компаній

PCRX AARD ACB ACRS ADIL

Оцінка PCRX vs аналоги Pharmaceuticals

P/E
51,9
▲ 132% sopra peer (22,4)
vs Peer
vs Settore
Sottovalutato
P/S
1,6
▼ 69% sotto peer (5,0)
vs Peer
vs Settore
Sottovalutato
P/B
1,1
▼ 47% sotto peer (2,1)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
—
▼ 0% sotto peer (2,0%)
vs Peer
vs Settore
Rendimento basso

Прибутковість PCRX vs аналоги Pharmaceuticals

ROE
2,8%
▲ 105% sopra peer (-54,3%)
vs Peer
vs Settore
Top livello
Net margin
3,0%
▲ 106% sopra peer (-47,4%)
vs Peer
vs Settore
Sotto media
Валова маржа
79,2%
▲ 16% sopra peer (68,3%)
vs Peer
vs Settore
Debole
ROA
1,4%
▲ 104% sopra peer (-37,4%)
vs Peer
vs Settore
Top livello

Фінансове здоровʼя PCRX vs аналоги Pharmaceuticals

D/E ratio
51,8
▲ 3264% sopra peer (1,5)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
5,3
▲ 56% sopra peer (3,4)
vs Peer
vs Settore
Sotto media
Beta
0,3
▼ 73% sotto peer (0,9)
vs Peer
vs Settore
Più volatile

Радар фундаменталів PCRX

PCRX Mediana peer Industria

PCRX прибутковість vs борг

Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio

PCRX vs аналоги: ключові метрики

Ultime notizie

Nessuna notizia correlata ancora